Shares of Medacta Group SA (OTCMKTS:MEDGF – Get Free Report) were down 3.3% on Thursday. The stock traded as low as $145.08 and last traded at $145.08. 100 shares traded hands during mid-day trading, an increase of 0% from the average session volume of 100 shares. The stock had previously closed at $150.0640.
Wall Street Analyst Weigh In
Separately, Deutsche Bank Aktiengesellschaft began coverage on Medacta Group in a research note on Tuesday, September 15th. They set a “hold” rating for the company. One analyst has rated the stock with a Hold rating. According to MarketBeat.com, the stock presently has a consensus rating of “Hold”.
Read Our Latest Stock Report on Medacta Group
Medacta Group Price Performance
The stock’s 50 day simple moving average is $142.56 and its 200-day simple moving average is $107.70.
About Medacta Group
Medacta Group is a Switzerland-based medical technology company focused on orthopedic care. Founded in 1999, the company develops and manufactures products and surgical techniques used in joint replacement and spine surgery.
Its portfolio includes implants and instruments for hip and knee replacement, as well as products for spine surgery and sports medicine. Medacta also provides surgical planning technologies and patient-specific solutions intended to support individualized procedures.
The company serves hospitals and surgeons internationally.
Recommended Stories
- Five stocks we like better than Medacta Group
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Medacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
